First fluconazole-resistant Candida auris isolated from fungal otitis in Iran

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 46

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CUMM-7-1_009

تاریخ نمایه سازی: 11 آذر 1402

Abstract:

Background and Purpose: Candida auris, as a new characterized pathogenic yeast,has attracted remarkable attention in the recent decade due to its rapid global emergence and multidrug resistance traits. This unique species is able to cause nosocomial outbreaks and tolerate adverse conditions; however, it has been mostly misidentified by conventional methods.Case report: This report aimed to describe the first fluconazole-resistant case of C.auris otitis in an immunocompetent patient in Iran. The isolate showed minimum inhibitory concentration of ≥ ۳۲ μg/ml for fluconazole; however, the patient was treated with topical clotrimazole and miconazole with no recurrence.Conclusion: This was the second strain of C. auris isolated from otitis in Iran which was fluconazole-resistant, unlike the first Iranian isolate.

Authors

Mojtaba Taghizadeh Armaki

Department of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

Saeid Mahdavi Omran

Department of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

Keivan Kiakojuri

Department of Ear, Nose, and Throat, Faculty of Medicine, Roohani Hospital, Babol University of Medical Sciences, Babol, Iran

Shaghayegh khojasteh

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Jalal Jafarzadeh

Department of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

Mahin Tavakoli

Department of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

Hamid Badali

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Iman Haghani

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Tahereh Shokohi

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Mohammad T. Hedayati

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Mahdi Abastabar

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Du H, Bing J, Hu T, Ennis CL, Nobile CJ, ...
  • Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM,Borman ...
  • Alfouzan W, Dhar R, Albarrag A, Al-Abdely H. The emergingpathogen ...
  • Ruiz GB, Lorenz A. What do we know about the ...
  • ۲۰۲۰ Oct ۹:۱۲۶۶۲۱ ...
  • Abastabar M, Haghani I, Ahangarkani F, Rezai MS, TaghizadehArmaki M, ...
  • Didehdar M, Shokohi T, Khansarinejad B, Sefidgar SA,Abastabar M, Haghani ...
  • Characterization of clinically important dermatophytes in Northof Iran using PCR-RFLP ...
  • Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I,Perlin ...
  • Clinical and Laboratory Standards Institute. ۲۰۱۸. ReferenceMethod for Broth Dilution ...
  • Chakrabarti, A.; Sood, P.; Rudramurthy, S.M.; Chen, S.; Kaur,H.; Capoor, ...
  • Milena Kordalewska, David S. Perlin. Identification of DrugResistant Candida auris. ...
  • Hyde, K.D.; Al-Hatmi, A.M.S.; Andersen, B.; Boekhout, T.;Buzina, W.; Dawson, ...
  • Fungal Diversity ۲۰۱۸ ...
  • Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K,Yamaguchi ...
  • Kim MN, Shin JH, Sung H, Lee K, Kim EC, ...
  • Clinical Infectious Diseases. ۲۰۰۹ Mar ۱۵;۴۸(۶):e۵۷-۶۱ ...
  • Pekard-Amenitsch S, Schriebl A, Posawetz W, Willinger B,Kölli B, Buzina ...
  • Riat A, Neofytos D, Coste A, Harbarth S, Bizzini A,Grandbastien ...
  • Yang A, Carlton DA, Hamula C, Patel G, Iloreta AM. ...
  • Schwartz IS, Hammond GW. Outbreak Detection: First reportedcase of multidrug-resistant ...
  • Sayeed MA, Farooqi J, Jabeen K, Awan S, Mahmood SF ...
  • Clinical spectrum and factors impacting outcome of Candidaauris: a single ...
  • Iguchi S, Mizushima R, Kamada K, Itakura Y, Yoshida A,Uzawa ...
  • Japanese Journal of Infectious Diseases. ۲۰۱۸:JJID-۲۰۱۷ ...
  • Alfouzan W, Dhar R, Albarrag A, Al-Abdely H. The emergingpathogen ...
  • Chowdhary A, Prakash A, Sharma C, et al. A multicentre ...
  • Pekard-Amenitsch S, Schriebl A, Posawetz W, Willinger B,Kölli B, Buzina ...
  • Lepak AJ, Zhao M, Berkow EL, Lockhart SR, Andes DR. ...
  • Pharmacodynamic optimization for treatment of invasive Candidaauris infection. Antimicrob Agents ...
  • Chow NA, de Groot T, Badali H, Abastabar M, Chiller ...
  • Emerging infectious diseases. ۲۰۱۹ Sep;۲۵(۹):۱۷۸۰. ...
  • نمایش کامل مراجع